About Gen-t
Gen-t is a company based in Sao Paulo (Brazil) founded in 2021. Gen-t has raised $1.94 million across 2 funding rounds from investors including Roivant Sciences, Eduardo Mufarej and Daniel Gold. Gen-t offers products and services including Genetic Bank and R&I Platform. Gen-t operates in a competitive market with competitors including Sapien Biosciences, Shivom, Reprotech, Sofia Bio and Bio Hubb, among others.
- Headquarter Sao Paulo, Brazil
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gen-t.science
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$1.94M (USD)
in 2 rounds
- InvestorsRoivant Sciences
& 3 more
Products & Services of Gen-t
Gen-t offers a comprehensive portfolio of products and services, including Genetic Bank and R&I Platform.
Stores and analyzes genetic samples from Brazilians for research purposes.
Integrates genomic data for health innovation and analysis.
Funding Insights of Gen-t
Gen-t has successfully raised a total of $1.94M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.94M
- Total Rounds 2
- First Round $1.94M
(Sep 2022)
- Investors Count 4
All 2 funding rounds of Gen-t with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | – | Seed | – | – | – |
| Sep 2022 | $1.94M | Seed | – | – |
4 investors in total: 1 institutional and 3 angel.
Investors in Gen-t
Gen-t has secured backing from 4 investors, including angel and institutional investors. Prominent investors backing the company include Roivant Sciences, Eduardo Mufarej and Daniel Gold.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | roivant.com | New York, United States | |
EM Eduardo Mufarej | Founder of GK Ventures, angel investor, focused on tech and impact startups. | – | unknown_25e1f060e8c74375a | - |
DG Daniel Gold | Angel investor and entrepreneur, focused on tech startups in India. | – | unknown_cee10f87b1ca4e54b | - |
AF Arminio Fraga | Brazilian economist, former Central Bank President, active in global investments | – | unknown_1056799c0023476c9 | - |
Investor details for Gen-t
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gen-t
1 people are tracked at Gen-t (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lygia Pereira | CEO | Leadership |
Complete people profiles for Gen-t
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Gen-t
3 dated milestones of Gen-t across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Gen-t is founded.
- Funding First funding round of $1.9M.
- Funding Latest funding round, Seed,.
Competitors of Gen-t
Gen-t operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sapien Biosciences, Shivom, Reprotech, Sofia Bio and Bio Hubb, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sapienbio.co.in | 2012 | Hyderabad, India | – | 38 | Biobanking services are offered for biomarker discovery and drug development. | |
| shivom.io | 2017 | Chandigarh, India | – | 3 | Blockchain-based genomics and data discovery platform is provided. | |
| reprotech.com | 1990 | Coconut Creek, United States | – | – | Provider of cryostorage and cryobank facilities for reproductive tissues | |
| sofiabio.com | 2005 | Sofia, Bulgaria | – | – | Provider of customized tissue procurement services for biopharmaceutical firms | |
| biohubb.com | 2024 | Jaipur, India | – | – | Biobank providing sample management and storage for scientific research institutions. | |
| biosend.org | 2015 | United States | – | – | A platform for secure storage and management of biological samples and associated data. |
Detailed competitors of Gen-t
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gen-t
The website of Gen-t (gen-t.science) receives about 21.6K visits a month.
- Monthly visits21.6K
▼ 10.2% vs previous month
Latest news on Gen-T
Complete news archive for Gen-t
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Gen-t
10 companies that operate in the same segment as Gen-t (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gen-t
Gen-t was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Gen-t is headquartered in Sao Paulo, Brazil.
Lygia Pereira is the current CEO of Gen-t.
Gen-t is a funded company, having raised a total of $1.94M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.94M, raised on Sep 2022.
Gen-t was founded in 2021 in Sao Paulo, Brazil, within the genomics sector. Gene bio-bank services are offered through a platform that facilitates genetic biobanking for research purposes. Genomic studies are enabled to advance precision medicine and pharmaceutical development. Operations focus on storing and accessing genetic data for scientific applications in the region.
Gen-t's top competitors include Sapien Biosciences, Shivom and Sofia Bio.
Gen-t offers Genetic Bank and R&I Platform.
Gen-t has 4 investors. Key investors include Roivant Sciences, Eduardo Mufarej, Daniel Gold, and Arminio Fraga.